207 related articles for article (PubMed ID: 14647428)
21. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
[TBL] [Abstract][Full Text] [Related]
22. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells.
Ben Aicha S; Lessard J; Pelletier M; Fournier A; Calvo E; Labrie C
Physiol Genomics; 2007 Oct; 31(2):295-305. PubMed ID: 17712038
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
Bose SK; Gibson W; Giri S; Nath N; Donald CD
Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.
Basrawala Z; Alimirah F; Xin H; Mohideen N; Campbell SC; Flanigan RC; Choubey D
Oncogene; 2006 May; 25(19):2812-7. PubMed ID: 16331249
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells.
Guzey M; Luo J; Getzenberg RH
J Cell Biochem; 2004 Oct; 93(2):271-85. PubMed ID: 15368355
[TBL] [Abstract][Full Text] [Related]
28. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
Oosterhoff JK; Grootegoed JA; Blok LJ
Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
[TBL] [Abstract][Full Text] [Related]
29. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells.
Sinha R; Pinto JT; Facompre N; Kilheffer J; Baatz JE; El-Bayoumy K
Nutr Cancer; 2008; 60(2):267-75. PubMed ID: 18444160
[TBL] [Abstract][Full Text] [Related]
30. REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells.
Oosterhoff JK; Penninkhof F; Brinkmann AO; Anton Grootegoed J; Blok LJ
Oncogene; 2003 May; 22(19):2920-5. PubMed ID: 12771942
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
Vercoutter-Edouart AS; Lemoine J; Le Bourhis X; Louis H; Boilly B; Nurcombe V; Révillion F; Peyrat JP; Hondermarck H
Cancer Res; 2001 Jan; 61(1):76-80. PubMed ID: 11196201
[TBL] [Abstract][Full Text] [Related]
32. [Androgens and increased lipogenesis in prostate cancer. Cell biologic and clinical perspectives].
Verhoeven G
Verh K Acad Geneeskd Belg; 2002; 64(3):189-95; discussion 195-6. PubMed ID: 12238242
[TBL] [Abstract][Full Text] [Related]
33. [Effects of vimentin on invasion and metastasis of prostate cancer cell lines PC-3M-1E8 and PC-3M-2B4].
Wei JC; Wu MF; Zhang YT; Zhao LP; Lu YP; Ma D
Ai Zheng; 2008 Jan; 27(1):30-4. PubMed ID: 18184460
[TBL] [Abstract][Full Text] [Related]
34. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
Yin H; Lowery M; Glass J
Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
Luker KE; Pica CM; Schreiber RD; Piwnica-Worms D
Cancer Res; 2001 Sep; 61(17):6540-7. PubMed ID: 11522652
[TBL] [Abstract][Full Text] [Related]
36. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
[TBL] [Abstract][Full Text] [Related]
37. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line.
Ischia R; Culig Z; Eder U; Bartsch G; Winkler H; Fischer-Colbrie R; Klocker H
Prostate Suppl; 1998; 8():80-7. PubMed ID: 9690667
[TBL] [Abstract][Full Text] [Related]
38. [Nuclear matrix proteins differentially expressed in human prostate cancer cell lines and benign prostatic hyperplasia epithelial cell line].
Sun TC; Xin L; Song LM; Zhou Y; Ning LF; Han LY; Guo Y; Yu HM; Wang HP
Zhonghua Nan Ke Xue; 2012 Jul; 18(7):583-9. PubMed ID: 22994041
[TBL] [Abstract][Full Text] [Related]
39. Proteomics in the analysis of prostate cancer.
Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
[No Abstract] [Full Text] [Related]
40. Transcription factor TFII-I causes transcriptional upregulation of GRP78 synthesis in prostate cancer cells.
Misra UK; Wang F; Pizzo SV
J Cell Biochem; 2009 Feb; 106(3):381-9. PubMed ID: 19097122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]